RAPP (Rapport Therapeutics) Dividend Yield % : 0.00% (As of Mar. 15, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Dividend Yield %?

As of today (2025-03-15), the Trailing Annual Dividend Yield of Rapport Therapeutics is 0.00%.

The historical rank and industry rank for Rapport Therapeutics's Dividend Yield % or its related term are showing as below:

RAPP's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

Rapport Therapeutics's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.

As of today (2025-03-15), the Forward Dividend Yield % of Rapport Therapeutics is 0.00%.

Rapport Therapeutics's Dividends per Share for the three months ended in Dec. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Rapport Therapeutics Dividend Yield % Historical Data

The historical data trend for Rapport Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Dividend Yield % Chart

Rapport Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Dividend Yield %

Rapport Therapeutics Quarterly Data
	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Dividend Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Rapport Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Rapport Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapport Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapport Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Rapport Therapeutics's Dividend Yield % falls into.

Rapport Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Rapport Therapeutics (NAS:RAPP) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Rapport Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapport Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1325 Boylston Street, Suite 401, Boston, MA, USA, 02215

Website

https://www.rapportrx.com

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.